AlertEdge.io
Single-Ticker Trade Brief
VEEV — Veeva Systems Report Date: 2026-07-29 14:46 UTC  |  Sector: Health Care  |  Rating:
RISK DISCLAIMER: This is an automated breakout signal. Always validate before entering a position.
▲ Breakout Signal — Volume Confirmed

VEEV closed above the $203.09 breakout level on 1.27x average volume. ATR-based levels set automatically. Next resistance target: $219.11.

Ticker
VEEV
Entry Price
$207.7
Breakout Level
$203.09
Stop Loss
$197.38
TP1 Target
$219.11
TP2 Target
$226.72
Risk / Reward
1 : 1.11
1.27x avg volume
View VEEV Chart on TradingView

Key Price Levels

TP1 Target
$219.11
Breakout Level
$203.09
Entry
$207.7
Stop Loss
$197.38

Fundamentals

P/E Ratio
36.87922
EPS (TTM)
5.63
Dividend Yield
0.0%
52-Wk High
310.5
52-Wk Low
148.05
Beta
0.941

Deep Dive Analysis — Claude Sonnet

VEEV — Veeva Systems | Trade Brief

SETUP

VEEV broke above $203.09 resistance on a strong gap-up session, clearing the level with conviction and closing near the day's high at $207.63. The candle shows a clean range expansion from open to close with no meaningful retracement intraday, signaling buyers are in control. Volume came in at 1.27x average — solid confirmation but not a blowout surge. The stock is recovering from a severe drawdown off its $310.50 52-week high, sitting roughly 33% below that level, meaning significant overhead supply remains. Entry here is not early-in-move — signal quality of 50/100 reflects that price has already made its initial move.

CATALYSTS

Most recent earnings on May 28 delivered a 13.3% beat, the strongest in five consecutive beat quarters, showing accelerating execution. News flow cites FY27 guidance upgrades and AI expansion initiatives actively shifting analyst sentiment. Multiple outlets are flagging VEEV as potentially 40-plus percent below fair value — that narrative creates a tailwind for re-rating. Life sciences SaaS remains a sticky, defensible niche with long contract cycles. Macro backdrop of rate stabilization generally supports valuation recovery in quality growth names.

RISKS

The 52-week high at $310.50 represents massive overhead supply — every rally attempt faces potential seller pressure from trapped longs. Risk/reward of 1:1.11 is barely acceptable and leaves little margin for error. Signal score of 50/100 confirms this is not a clean early entry. Insider activity shows multiple executives selling shares in July 2026, including a $1M sale by President Schwenger — that is a meaningful red flag against the bullish thesis. Next earnings are not until September 2026, removing a near-term catalyst to drive continued momentum. A failure to hold $203 on any pullback invalidates the setup quickly.

CONVICTION: Medium

Five consecutive earnings beats and a credible undervaluation narrative support the bull case, but insider selling, poor risk/reward, extended entry timing, and heavy overhead supply collectively cap conviction here.